These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15571923)

  • 1. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
    J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
    Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
    Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
    Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
    Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
    Martin S; Hibino T; Faust A; Kleemann R; Kolb H
    J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
    Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
    J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic glycolipid ligands as novel therapeutics for multiple sclerosis].
    Yamamura T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):909-11. PubMed ID: 16447760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.
    Weiss L; Zeira M; Reich S; Har-Noy M; Mechoulam R; Slavin S; Gallily R
    Autoimmunity; 2006 Mar; 39(2):143-51. PubMed ID: 16698671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1.
    Nakazawa T; Satoh J; Takahashi K; Sakata Y; Ikehata F; Takizawa Y; Bando SI; Housai T; Li Y; Chen C; Masuda T; Kure S; Kato I; Takasawa S; Taniguchi T; Okamoto H; Toyota T
    J Autoimmun; 2001 Sep; 17(2):119-25. PubMed ID: 11591120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.